|
|
|
|
|
|
|
|
|
|
"The Company is also conducting a Phase I/II trial with DCVax(R) for recurrent metastatic ovarian cancer."
Monday, February 08, 2010
Northwest Biotherapeutics Inc. - press release
"The Company is also conducting a Phase I/II trial with DCVax(R) for recurrent metastatic ovarian cancer."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.